Molecular Partners AG
MOLNNASDAQHealthcare● Active
$3.95
$-0.15(-3.66%)
Market Cap$148168932
P/E Ratio—
52W High$5.36
52W Low$3.41
Molecular Partners AG (MOLN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MOLN · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.01B | $0.19B | $0.01B |
| Cost of Revenue | $0.00B | $0.05B | $0.05B | $0.05B | $0.06B |
| Gross Profit | $0.00B | ($0.04B) | ($0.04B) | $0.14B | ($0.05B) |
| Gross Margin %(computed) | — | -855.81% | -579.80% | 73.23% | -497.19% |
| Operating Expenses | |||||
| R&D Expenses | $0.04B | $0.05B | $0.05B | $0.05B | $0.06B |
| G&A Expenses | $0.01B | $0.02B | $0.02B | $0.02B | $0.02B |
| Total Operating Expenses | $0.06B | $0.02B | $0.02B | $0.07B | $0.07B |
| Operating Income | ($0.06B) | ($0.06B) | ($0.06B) | $0.12B | ($0.06B) |
| Operating Margin %(computed) | — | — | -868.26% | 61.52% | -679.72% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.06B) | ($0.05B) | ($0.06B) | $0.12B | ($0.06B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.06B) | ($0.05B) | ($0.06B) | $0.12B | ($0.06B) |
| Net Margin %(computed) | — | — | -880.70% | 62.17% | -683.65% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.65 | $-1.59 | $-1.89 | $3.63 | $-2.06 |
| Wtd Avg Shares | 0.04B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | ($0.06B) | ($0.05B) | ($0.06B) | $0.12B | ($0.06B) |
| EBITDA Margin %(computed) | — | — | -845.62% | 62.78% | -650.18% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CHF · B
Explore more Molecular Partners AG data
About Molecular Partners AG (MOLN) Income Statement
Molecular Partners AG (MOLN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MOLN reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.06B) — a net profit margin of —.
Frequently asked questions
MOLN · 4 questionsMolecular Partners AG (MOLN) reported revenue of $0.00B for 2025, down 100.0% year-over-year.
MOLN revenueMOLN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09